Search - tctmd.com

Displaying 101 - 120 of 3565

Sort: Relevancy | Date

Presentation TCT 2016

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee

October 31, 2016

Presentation TCT 2016

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

Presenter: Jean-Claude Laborde, Thomas Walther, Jalal Zamani

October 31, 2016

Presentation TCT 2016

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr

October 31, 2016

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Presentation TCT 2016

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

Presenter: Neil E. Moat, John G. Webb, Eric Van Belle

October 31, 2016

Presentation TCT 2016

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande

October 31, 2016

Presentation TCT 2016

TCT 1515: The Dance of the Corevalve

Presenter: Jean-Claude Laborde, Thomas Walther, Smriti Saraf

October 31, 2016

Presentation TCT 2016

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

Presenter: Neil E. Moat, John G. Webb, Scott Lim

October 31, 2016

Presentation TCT 2016

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Presenter: William A. Gray, Stephan Windecker

October 31, 2016

Presentation TCT 2016

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

Presenter: Neil E. Moat, John G. Webb, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

Presenter: Jean-Claude Laborde, Thomas Walther, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, M. Rizwan Sardar

October 31, 2016

Presentation TCT 2016

Case #2: A TAVR Complication to Learn From

Presenter: Antonio Colombo, Jeffrey W. Moses, Augusto D. Pichard

October 31, 2016

Presentation TCT 2016

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani

October 31, 2016

Presentation TCT 2016

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Presenter: Raj Makkar, Lars Sondergaard, Davide Capodanno

October 31, 2016

Presentation TCT 2016

Case Resolution: How Did We Treat this Patient?

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

Presenter: Raj Makkar, Lars Sondergaard, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Farzin Beygui

October 31, 2016

Presentation TCT 2016

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Presenter: Jean-Claude Laborde, Thomas Walther, Ulrich Schafer

October 31, 2016

Advertisement

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

TCT 1515: The Dance of the Corevalve

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

Case #2: A TAVR Complication to Learn From

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Case Resolution: How Did We Treat this Patient?

Controversy 5. Adjunctive Pharmacotherapy for TAVR: Real World Usage Patterns of Antiplatelet and Antithrombotic Agents

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content